Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

Clinical trial NCT00753675 · COMPLETED

Trial details

NCT number: NCT00753675
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer Gallbladder Cancer Cancer Of The Extrahepatic Bile Duct Ampullary Carcinoma

Start date: 2008-10-01
Primary completion: 2012-09-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.